VR Logo

Aurobindo Pharma Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1986

Chairman: K Ragunathan

Managing Director: N Govindarajan

Group: Aurobindo

Listing: NSE: AUROPHARMA, BSE: 524804

Headquarters: Hyderabad, Telangana

Website: www.aurobindo.com

Key Facts

Market cap: R 53,124.12 Cr

Revenue (TTM): R 23,098.51 Cr

Earnings (TTM): R 2,844.69 Cr

Cash: R 2,842.17 Cr

Total Debt: R 5,561.97 Cr

Promoters' ownership: 52.01%

Liquidity: High

52 Week range: R 288.85 - 923.05

Face value: R1.00

Shares outstanding: 58,59,38,609

10 Years Aggregate:

  • CFO: 15,504.43 Cr
  • EBITDA: 26,293.18 Cr
  • Net Profit: 15,415.22 Cr

Stock Performance

Time Period Aurobindo Pharma S&P BSE Sensex S&P BSE Healthcare
YTD98.41-7.7939.70
1 month16.783.7215.24
3 months39.7720.9824.56
1 Year63.413.6849.24
3 Years7.755.6310.53
5 Years3.246.141.38
10 Years25.237.6812.85
As on 07-Aug-2020
Year Aurobindo Pharma S&P BSE Sensex S&P BSE Healthcare
2019-37.6914.38-3.55
20186.505.87-5.89
20172.7927.910.49
2016-24.061.95-12.88
201555.43-5.0315.06
2014189.9429.8947.43
2013103.058.9822.55